Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

126.92
Delayed Data
As of May 26
 -0.61 / -0.48%
Today’s Change
109.32
Today|||52-Week Range
129.00
+10.16%
Year-to-Date
JNJ Regular Dividend: JNJ began trading ex-dividend on 05/25/17. A $0.84 dividend will be paid to shareholders of record as of 05/30/17.
Multiple-Plaintiff Trial Involving J&J Set to Start
May 26 / GuruFocus News - Paid Partner Content
Here's Why Alexion Pharma (ALXN) Stock is Sinking Today
May 23 / Zacks.com - Paid Partner Content
Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote
May 26 / Zacks.com - Paid Partner Content
Chinese tech companies top world in trademark applications
May 22 / FT.com - Paid Partner Content
Buffett Stocks in Focus: Southwest Airlines
May 25 / GuruFocus News - Paid Partner Content
Dow 30 Stock Roundup: Home Depot, Cisco, Wal-Mart Beat on Earnings
May 19 / Zacks.com - Paid Partner Content
Planet office: the academics who study the secrets of work
May 25 / FT.com - Paid Partner Content
Why Is Johnson & Johnson (JNJ) Up 4.4% Since the Last Earnings Report?
May 19 / Zacks.com - Paid Partner Content
Johnson & Johnson Settles U.S. Drug Manufacturing Probe
May 24 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More
May 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close127.53
Today’s open127.23
Day’s range126.83 - 127.67
Volume4,005,234
Average volume (3 months)6,475,347
Market cap$341.9B
Dividend yield2.65%
Data as of 4:02pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+8.21%
Earnings growth (this year)+5.45%
Earnings growth (next 5 years)+5.95%
Revenue growth (last year)+2.47%
P/E ratio21.3
Price/Sales4.47
Price/Book4.88

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.02-0.06%
NVSNovartis-0.72-0.89%
MRKMerck-0.12-0.18%
SNYSanofi-0.03-0.06%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 18, 2017
EPS forecast (this quarter)$1.79
Annual revenue (last year)$71.9B
Annual profit (last year)$16.5B
Net profit margin22.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Vice President
Dominic J. Caruso
Corporate headquarters
New Brunswick, New Jersey

Forecasts